Together, these data suggests that OGT and O-GlcNAc protects GATAD2B from proteasome-dependent degradation mediated by the E3 ligase ITCH and also identifies ITCH as a regulator of breast cancer stem cell functions. The gene discussed is GATAD2B; the disease is breast carcinoma.